Please login to the form below

Not currently logged in
Email:
Password:

Kesimpta

This page shows the latest Kesimpta news and features for those working in and with pharma, biotech and healthcare.

Novartis announces positive long-term data for relapsing MS treatment Kesimpta

Novartis announces positive long-term data for relapsing MS treatment Kesimpta

Novartis has announced positive new long-term data from an open-label extension study of its multiple sclerosis (MS) treatment, Kesimpta (ofatumumab). ... versus those who started on disease modifying therapy (Aubagio) teriflunomide and were later

Latest news

More from news
Approximately 5 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Self-administered injectables, such as Novo Nordisk’s recently approved therapy for adult growth hormone deficiency (GHD), Sogroya (somapacitan), and Novartis’ much-hyped MS treatment, Kesimpta (ofatumumab), will be tested in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....